GlassScriptPhysician profile
Sonya S Patel
NPI 1659360139
$1,564.92
in general payments reported to CMS, 2019-2025
13 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $20.62 · 2022: $158 · 2023: $358 · 2024: $159 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $248.28 | 2022-2023 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $225.81 | 2019 | |
| Eisai INC. | $190.25 | 2019-2020 | |
| Stryker Corporation | $139.91 | 2019 | |
| Harrow Eye, LLC | $131.54 | 2024 | |
| Ceribell, INC. | $125.00 | 2025 | Pocket Eeg Device |
| Genentech USA, INC. | $124.59 | 2019 | |
| Horizon Therapeutics Plc | $124.55 | 2023 | Uplizna |
| Biogen, INC. | $99.20 | 2023 | Vumerity |
| Mdd US Operations, LLC | $83.30 | 2019 | |
| Argenx US, INC. | $27.95 | 2024 | Vyvgart Hytrulo |
| Pfizer INC. | $22.68 | 2023 | |
| Abbvie INC. | $21.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.